Mathijs C. Bunck, MD, PhD

5.1K posts

Mathijs C. Bunck, MD, PhD banner
Mathijs C. Bunck, MD, PhD

Mathijs C. Bunck, MD, PhD

@1900b

Physician Scientist | Clinical Trialist | Professional Reader | Cardiometabolic Endocrinology | Existentialist | Astronaut Wannabe | 🇳🇱🇺🇸

Indianapolis, IN Katılım Ocak 2009
209 Takip Edilen200 Takipçiler
Mathijs C. Bunck, MD, PhD retweetledi
The Nobel Prize
The Nobel Prize@NobelPrize·
Medicine laureate Rosalyn Yalow’s parents allegedly encouraged her to become a teacher for “practical reasons”. Luckily, she pursued science and pioneered the radio-immunoassay (RIA) method, which revolutionised the study of hormones. #NobelPrize
The Nobel Prize tweet media
English
6
48
189
7.5K
Mathijs C. Bunck, MD, PhD retweetledi
Robert Greene
Robert Greene@RobertGreene·
In order to master a field, you must love the subject and feel a profound connection to it. Your interest must transcend the field and border on the religious.
English
137
543
3.4K
70.8K
Mathijs C. Bunck, MD, PhD retweetledi
Scott Isaacs
Scott Isaacs@scottisaacsmd·
Honored to share that the new AACE Consensus Statement “Algorithm for Management of Adults With Type 2 Diabetes – 2026 Update” has been released for member review. Grateful to my coauthors and AACE colleagues for their incredible work on this important guidance for improving care for people with type 2 diabetes. endocrinepractice.org/article/S1530-…
Scott Isaacs tweet media
English
2
61
170
13.7K
Mathijs C. Bunck, MD, PhD retweetledi
Daniel J Drucker
Daniel J Drucker@DanielJDrucker·
Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: ⁦@CellRepMedcell.com/cell-reports-m…
English
2
31
111
15.5K
Mathijs C. Bunck, MD, PhD
@CMichaelGibson Biology is no longer the dark art of random discovery. It’s a predictable, compounding execution loop. No it’s not. It’s trial and error…
English
0
0
1
22
C. Michael Gibson MD
C. Michael Gibson MD@CMichaelGibson·
What are your thoughts on #computethecure ?
Dustin@r0ck3t23

Jensen Huang just called the exact top of the pharmaceutical industry. Not a pivot. Not a disruption. An extinction event. Huang: “Where do I think the next amazing revolution is going to come? And this is going to be flat out one of the biggest ones ever. There’s no question that digital biology is going to be it.” The medical establishment has spent centuries playing a chaotic game of trial and error. We’re about to mathematically engineer the human operating system. Huang: “For the very first time in human history, biology has the opportunity to be engineering, not science. When something becomes engineering, not science, it becomes less sporadic and exponentially improving.” Biology is no longer the dark art of random discovery. It’s a predictable, compounding execution loop. Translate the chaotic variables of chemistry into the laws of computer science and you stop waiting for accidental breakthroughs. You simply compute the cure. That line should terrify every pharmaceutical executive alive. Huang: “It can compound on the benefits of the previous years. And every researcher’s contributions compound on each other.” For decades, drug discovery has been an isolated, artisanal process. One lab. One team. One molecule. Years of blind iteration. The algorithm just shattered that entire bottleneck. Every failed protein fold, every successful synthetic molecule instantly trains the foundational model. Makes the next iteration mathematically smarter. Huang: “We’re going to have incredible tools that bring the world of biology, which is very chaotic and constantly changing and diverse and complex, into the world of computer science. And that is going to be profound.” Incumbent pharma looks at the human body and sees an unmanageable wall of variables. Engineers look at that exact same body and see raw data waiting to be compiled. No longer guessing how a molecule will react in the physical world. Running millions of zero-cost simulated iterations before a single test tube is ever touched. Rip the chaotic friction out of the physical lab and drop it directly into a massive GPU cluster? The timeline to map, edit, and optimize the biological machine doesn’t shrink. It collapses.

English
9
1
14
5.2K
Mathijs C. Bunck, MD, PhD
@r0ck3t23 Biology is no longer the dark art of random discovery. It’s a predictable, compounding execution loop. No it’s not. It’s trial and error…
English
0
0
1
31
Dustin
Dustin@r0ck3t23·
Jensen Huang just called the exact top of the pharmaceutical industry. Not a pivot. Not a disruption. An extinction event. Huang: “Where do I think the next amazing revolution is going to come? And this is going to be flat out one of the biggest ones ever. There’s no question that digital biology is going to be it.” The medical establishment has spent centuries playing a chaotic game of trial and error. We’re about to mathematically engineer the human operating system. Huang: “For the very first time in human history, biology has the opportunity to be engineering, not science. When something becomes engineering, not science, it becomes less sporadic and exponentially improving.” Biology is no longer the dark art of random discovery. It’s a predictable, compounding execution loop. Translate the chaotic variables of chemistry into the laws of computer science and you stop waiting for accidental breakthroughs. You simply compute the cure. That line should terrify every pharmaceutical executive alive. Huang: “It can compound on the benefits of the previous years. And every researcher’s contributions compound on each other.” For decades, drug discovery has been an isolated, artisanal process. One lab. One team. One molecule. Years of blind iteration. The algorithm just shattered that entire bottleneck. Every failed protein fold, every successful synthetic molecule instantly trains the foundational model. Makes the next iteration mathematically smarter. Huang: “We’re going to have incredible tools that bring the world of biology, which is very chaotic and constantly changing and diverse and complex, into the world of computer science. And that is going to be profound.” Incumbent pharma looks at the human body and sees an unmanageable wall of variables. Engineers look at that exact same body and see raw data waiting to be compiled. No longer guessing how a molecule will react in the physical world. Running millions of zero-cost simulated iterations before a single test tube is ever touched. Rip the chaotic friction out of the physical lab and drop it directly into a massive GPU cluster? The timeline to map, edit, and optimize the biological machine doesn’t shrink. It collapses.
English
341
891
3.7K
764.2K
Mathijs C. Bunck, MD, PhD retweetledi
The Nobel Prize
The Nobel Prize@NobelPrize·
Today is March 14 (3.14) – Pi day. The date today resembles 3.14159, the common approximation of the mathematical constant Pi, or π. This concurrence has given rise to an annual celebration from 1:59 pm - also the time of publication of this post (CET). What is Pi? Understanding Pi is essential if you want to make calculations for circles, cylinders, spheres, and anything circular, even an ellipse. Pi is the ratio of the circumference of a circle to its diameter. It doesn't matter how big or small the circle is - the ratio stays the same. Properties like this that stay the same when you change other attributes are called constants. How are you celebrating Pi day?
The Nobel Prize tweet media
English
65
981
2.7K
93.1K
Mathijs C. Bunck, MD, PhD retweetledi
Brandon Luu, MD
Brandon Luu, MD@BrandonLuuMD·
Dog contact was linked to 64% lower 5-year mortality in cancer patients. Possible mechanisms include physical activity, psychosocial support, and microbiome changes.
Brandon Luu, MD tweet media
English
20
260
1.2K
78.6K
Harriette Van Spall, MD MPH 🇨🇦
Can you drop suggestions for essential peer-reviewed publications in #HFpEF or #CKM disease? Please suggest or post landmark clinical trials, well designed meta-analyses, guidelines, position statements, or review articles. PS. What spring looks like 🥶 #MedEd
Harriette Van Spall, MD MPH 🇨🇦 tweet media
English
4
1
21
2.1K
Mathijs C. Bunck, MD, PhD retweetledi
Abdulla A. Damluji, MD, PhD
Abdulla A. Damluji, MD, PhD@DrDamluji·
Cardiovascular Statistics in the United States, 2026: JACC Stats: @JACCJournals 🥸Beast of a document - and a brilliant idea @rkwadhera competing with heart disease and stroke statistics! 😱Few facts below with figures 👇👇👇👇
Abdulla A. Damluji, MD, PhD tweet media
English
6
13
70
8.1K
Mathijs C. Bunck, MD, PhD
@BevTchangMD and then FDA will say: "what is the clinical meaningful of this..." PRO's are important for payers imho. Doubt if we will see it ending up in obesity/OSA label indication statements or section 14.
Brownsburg, IN 🇺🇸 English
0
0
1
10
Beverly G. Tchang, MD
Beverly G. Tchang, MD@BevTchangMD·
FWIW, the IWQOL-Lite-CT does capture significant physical, function, and psychosocial benefit all around 👉pmc.ncbi.nlm.nih.gov/articles/PMC11… I wish I had an easy translation for patients for the meaningful "20-point" improvements-- "It's like surviving 3 playdates with your grandkids instead of 1"?? HT: @MichelleCardel
Beverly G. Tchang, MD@BevTchangMD

Sharing with permission: Patient's route to work includes subway rides, and for the past couple of weeks, the escalators were broken. Several flights of stairs climbed daily--previously incomprehensible--and now no 😅, ⬇️50 lbs on tirzepatide #nonscalevictory #obesitycare #obesity (Side note: I wish some of these NSVs were validated on a #research level because, to be frank, improvement in hand grip strength or sit-to-stand test just isn't as 🎉🎇 for the patient)

English
3
1
7
840
Mathijs C. Bunck, MD, PhD retweetledi
Daniel J Drucker
Daniel J Drucker@DanielJDrucker·
GLP-1 RA exposure in systemic lupus erythematosus patients with type 2 diabetes mellitus is associated with reduced risks of lupus nephritis, and systemic lupus erythematosus flares amjmed.com/article/S0002-…
English
1
9
34
2.4K
Mathijs C. Bunck, MD, PhD retweetledi
Eli Lilly and Company
Eli Lilly and Company@EliLillyandCo·
We tested mass-produced knockoffs of our diabetes and obesity medicines that compounders mixed with vitamin B12 – an additive frequently used by businesses trying to evade FDA regulations. The results found a potentially dangerous impurity with unknown risks. Read more: e.lilly/4ul4dRn
Eli Lilly and Company tweet media
English
14
10
45
7.4K
Mathijs C. Bunck, MD, PhD
Ok I get it: SURPASS-CVOT is technically a study in people with T2D whereas the others are in people living with overweight or obesity with or without T2D. This raises the question: do we need to keep this artifical dichotomy? We do not specifically call out other comorbidies?
Brownsburg, IN 🇺🇸 English
0
0
0
16
Mathijs C. Bunck, MD, PhD retweetledi
Daniel J Drucker
Daniel J Drucker@DanielJDrucker·
Congratulations to Prof Naveed Sattar, MBChB, PhD, FRCP (Glasg), FRCPath, FRSE, FMedSci: 2026 Outstanding Achievement in Clinical Diabetes Research Awardee @AmDiabetesAssn
Daniel J Drucker tweet media
English
1
5
38
2.1K
Mathijs C. Bunck, MD, PhD retweetledi
Prof Kamlesh Khunti
Prof Kamlesh Khunti@kamleshkhunti·
📉 Big shift in diabetes mortality trends Across 11 countries & 1.7B person-years: ❤️ CVD deaths ↓ sharply (–8% to –25% every 5 yrs) 🧠 Dementia deaths ↑ markedly 🎗️ Cancer now the leading cause of death in people with diabetes in several countries 🚨 Cardiovascular disease is no longer universally the main cause of death in diabetes. #Diabetes #CVD #PublicHealth sciencedirect.com/science/articl… @DiannaMagliano et al
Prof Kamlesh Khunti tweet media
English
2
15
27
3K